Astellas Pharma Inc. Announces CEO Changes, Effective April 1, 2023
in the finances and markets of each country due to the COVID-19 crisis, but the new top management has the ability to flexible in response to such changes. Naoki Okamura - Date of Birth: September 18, 1962. Place of Birth: Shizuoka Prefecture - Career History: April 2022 Representative Director, Executive Vice President and Chief Strategy Officer (CStO), the Company (present post) March 2022 - Representative Director, Executive Vice President, Chief Strategy Officer and Chief Business Officer (CStO and CBO), the Company September 2021 - Representative Director, Executive Vice President, Chief Strategy Officer, Chief Financial Officer and Chief Business Officer (CStO & CFO, and CBO), the Company October 2019 - Representative Director, Executive Vice President, Chief Strategy Officer and Chief Financial Officer, (CStO & CFO), the Company June 2019 - Representative Director, Executive Vice President, Chief Strategy Officer (CStO), the Company April 2019 - Corporate Executive Vice President, Chief Strategy Officer (CStO), the Company April 2018 - Corporate Executive, Chief Strategy Officer (CStO), the Company June 2016 - Corporate Executive, Vice President, Corporate Planning, the Company April 2016 - Vice President, Corporate Planning, the Company July 2014 - Vice President, Licensing & Alliances, the Company April 2012 - Senior Vice President, Chief Strategy Officer, Astellas Pharma Europe Ltd. October 2010 - President & CEO, OSI Pharmaceuticals Inc. April 1986 Joined the Company - Education - March 1985 University of Tokyo, Faculty of Pharmacy. Kenji Yasukawa - Date of Birth: June 7, 1960. Place of Birth: Tokyo. Career History: April 2018 - Representative Director, President and CEO, the Company (present post)- June 2017 Representative Director, Executive Vice President, Chief Strategy Officer and Chief Commercial Officer, the Company - April 2017 Senior Corporate Executive, Senior Vice President, Chief Strategy Officer and Chief Commercial Officer, the Company - June 2012 Senior Corporate Executive, Senior Vice President and Chief Strategy Officer, the Company - April 2012 Corporate Executive, Senior Vice President and Chief Strategy Officer, the Company - April 2011 Corporate Executive, Vice President, Product & Portfolio Strategy, the Company - October 2010 Corporate Executive of the Company, Therapeutic Area Head, Urology, Astellas Pharma Global Development Inc. - June 2010 Corporate Executive of the Company, Therapeutic Area Head, Urology, Astellas Pharma Europe B.V. - April 2005 Vice President, Project Management, Urology, the Company - April 1986 Joined the Company (former Yamanouchi Pharmaceutical Co. Ltd.)- Education: July 2001 Showa University Graduate School of Pharmaceutical Sciences, Japan, Ph.D. in Pharmaceutical Sciences - March 1986 University of Tokyo, Master of Science, Agriculture.